The DOI matches its Crossref record; 692 of the 692 references it cites were found in a registry or an index.
Endocannabinoid-Mediated Control of Synaptic Transmission
Abstract
The discovery of cannabinoid receptors and subsequent identification of their endogenous ligands (endocannabinoids) in early 1990s have greatly accelerated research on cannabinoid actions in the brain. Then, the discovery in 2001 that endocannabinoids mediate retrograde synaptic signaling has opened up a new era for cannabinoid research and also established a new concept how diffusible messengers modulate synaptic efficacy and neural activity. The last 7 years have witnessed remarkable advances in our understanding of the endocannabinoid system. It is now well accepted that endocannabinoids are released from postsynaptic neurons, activate presynaptic cannabinoid CB 1 receptors, and cause transient and long-lasting reduction of neurotransmitter release. In this review, we aim to integrate our current understanding of functions of the endocannabinoid system, especially focusing on the control of synaptic transmission in the brain. We summarize recent electrophysiological studies carried out on synapses of various brain regions and discuss how synaptic transmission is regulated by endocannabinoid signaling. Then we refer to recent anatomical studies on subcellular distribution of the molecules involved in endocannabinoid signaling and discuss how these signaling molecules are arranged around synapses. In addition, we make a brief overview of studies on cannabinoid receptors and their intracellular signaling, biochemical studies on endocannabinoid metabolism, and behavioral studies on the roles of the endocannabinoid system in various aspects of neural functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 692
Regulation of a Neuronal Form of Focal Adhesion Kinase by Anandamide
Derkinderen, P., Toutant, M., Burgaya, F., Le Bert, M., Siciliano, J. C., de Franciscis, V., Gelman, M., & Girault, J.-A. (1996) · Science · doi:10.1126/science.273.5282.1719 · Cited by 180
Ohno‐Shosaku, T., Shosaku, J., Tsubokawa, H., & Kano, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01929.x · Cited by 179
Self-citationYoshida, T., Hashimoto, K., Zimmer, A., Maejima, T., Araishi, K., & Kano, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01690.2002 · Cited by 179
Self-citationBouthenet, M. L., Ruat, M., Sales, N., Garbarg, M., & Schwartz, J. C. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90167-4 · Cited by 178
Cannabinoid Receptor Modulation of Synapses Received by Cerebellar Purkinje Cells
Takahashi, K. A., & Linden, D. J. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.3.1167 · Cited by 177
Critical Enzymes Involved in Endocannabinoid Metabolism
Basavarajappa, B. (2007) · Protein & Peptide Letters · doi:10.2174/092986607780090829 · Cited by 177
Functional CB1 Receptors Are Broadly Expressed in Neocortical GABAergic and Glutamatergic Neurons
Hill, E. L., Gallopin, T., Férézou, I., Cauli, B., Rossier, J., Schweitzer, P., & Lambolez, B. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00603.2006 · Cited by 176
Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters
Arévalo, C., de Miguel, R., & Hernández-Tristán, R. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00578-0 · Cited by 175
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences
Le Foll, B., & Goldberg, S. R. (2004) · NeuroReport · doi:10.1097/00001756-200409150-00028 · Cited by 174
Porter, J. T., Cauli, B., Staiger, J. F., Lambolez, B., Rossier, J., & Audinat, E. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00367.x · Cited by 173
Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain
McCune, S. K., Voigt, M. M., & Hill‡, J. M. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90116-w · Cited by 173
Sullivan, J. M. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.3.1286 · Cited by 173
Bridges, D., Rice, A. S. C., Egertová, M., Elphick, M. R., Winter, J., & Michael, G. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00200-8 · Cited by 172
Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells
Muccioli, G. G., Xu, C., Odah, E., Cudaback, E., Cisneros, J. A., Lambert, D. M., López Rodríguez, M. L., Bajjalieh, S., & Stella, N. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4830-06.2007 · Cited by 172
Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice
Häring, M., Marsicano, G., Lutz, B., & Monory, K. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.021 · Cited by 171
Laviolette, S. R., & Grace, A. A. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6027-5 · Cited by 170
Jung, K.-M., Astarita, G., Zhu, C., Wallace, M., Mackie, K., & Piomelli, D. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037796 · Cited by 170
Gómez del Pulgar, T., de Ceballos, M. L., Guzmán, M., & Velasco, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205797200 · Cited by 169
Nakamura, M., Sato, K., Fukaya, M., Araishi, K., Aiba, A., Kano, M., & Watanabe, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03768.x · Cited by 168
Self-citationInhibition of Interneuron Firing Extends the Spread of Endocannabinoid Signaling in the Cerebellum
Kreitzer, A. C., Carter, A. G., & Regehr, W. G. (2002) · Neuron · doi:10.1016/s0896-6273(02)00695-5 · Cited by 167
Ohno‐Shosaku, T., Matsui, M., Fukudome, Y., Shosaku, J., Tsubokawa, H., Taketo, M. M., Manabe, T., & Kano, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02732.x · Cited by 166
Self-citationYin, H. H., & Lovinger, D. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510797103 · Cited by 166
Brown, S. P., Safo, P. K., & Regehr, W. G. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0918-04.2004 · Cited by 166
Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons
Losonczy, A., Biró, Á. A., & Nusser, Z. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304752101 · Cited by 165
Saario, S. M., Savinainen, J. R., Laitinen, J. T., Järvinen, T., & Niemi, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.003 · Cited by 163
The expanding field of cannabimimetic and related lipid mediators
Bradshaw, H. B., & Walker, J. M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706093 · Cited by 163
Bisogno, T., Melck, D., De Petrocellis, L., & Di Marzo, V. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722113.x · Cited by 162
Activation of Group I mGluRs Is Necessary for Induction of Long-Term Depression at Striatal Synapses
Sung, K.-W., Choi, S., & Lovinger, D. M. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.5.2405 · Cited by 162
Nyíri, G., Cserép, C., Szabadits, E., MacKie, K., & Freund, T. F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.026 · Cited by 161
The uptake by cells of 2‐arachidonoylglycerol, an endogenous agonist of cannabinoid receptors
Bisogno, T., Maccarrone, M., De Petrocellis, L., Jarrahian, A., Finazzi‐Agrò, A., Hillard, C., & Di Marzo, V. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02072.x · Cited by 160
Differential effects of Δ 9 -THC on spatial reference and working memory in mice
S., V., R., H., B., M., & A., L. (2001) · Psychopharmacology · doi:10.1007/s002130100780 · Cited by 160
CB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids
McAllister, S. D., & Glass, M. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0344 · Cited by 159
Prostamides (prostaglandin‐ethanolamides) and their pharmacology
Woodward, D. F., Liang, Y., & Krauss, A. H. ‐. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707434 · Cited by 158
Chen, K., Neu, A., Howard, A. L., Földy, C., Echegoyen, J., Hilgenberg, L., Smith, M., Mackie, K., & Soltesz, I. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3966-06.2007 · Cited by 158
Associative Short-Term Synaptic Plasticity Mediated by Endocannabinoids
Brenowitz, S. D., & Regehr, W. G. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.045 · Cited by 158
McDonald, A. J., & Mascagni, F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00380-3 · Cited by 157
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example
Wager‐Miller, J., Westenbroek, R. E., & Mackie, K. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00151-2 · Cited by 156
The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus
Takahashi, K. A., & Castillo, P. E. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.024 · Cited by 156
Jin, X.-H., Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606369200 · Cited by 155
Identification and characterisation of a novel splice variant of the human CB1 receptor
Ryberg, E., Vu, H. K., Larsson, N., Groblewski, T., Hjorth, S., Elebring, T., Sjögren, S., & Greasley, P. J. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.085 · Cited by 154
Roberts, E. B., & Ramoa, A. S. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.81.5.2587 · Cited by 153
Lü, Y.-F., & Hawkins, R. D. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.88.3.1270 · Cited by 153
Nucleotide sequence of a human cannabinoid receptor cDNA
Gérard, C., Mollereau, C., Vassart, G., & Parmentier, M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.23.7142 · Cited by 152
Further evidence for the existence of a specific process for the membrane transport of anandamide
Ligresti, A., Morera, E., van der Stelt, M., Monory, K., Lutz, B., Ortar, G., & Marzo, V. D. (2004) · Biochemical Journal · doi:10.1042/bj20031812 · Cited by 149
Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain
Jhaveri, M. D., Richardson, D. S., & Chapman, V. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707433 · Cited by 147
WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors
Pamplona, F. A., & Takahashi, R. N. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.026 · Cited by 147
Biosynthetic Pathways of the Endocannabinoid Anandamide
Okamoto, Y., Wang, J., Morishita, J., & Ueda, N. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790155 · Cited by 147
Kondo, S., Kondo, H., Nakane, S., Kodaka, T., Tokumura, A., Waku, K., & Sugiura, T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00581-x · Cited by 147
Ryanodine receptor‐mediated intracellular calcium release in rat cerebellar Purkinje neurones.
Kano, M., Garaschuk, O., Verkhratsky, A., & Konnerth, A. (1995) · The Journal of Physiology · doi:10.1113/jphysiol.1995.sp020857 · Cited by 146
Self-citationKaufman, E. N., & Jain, R. K. (1992) · PubMed · Cited by 145
Haj‐Dahmane, S., & Shen, R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3258-04.2005 · Cited by 144
Emerging roles for endocannabinoids in long‐term synaptic plasticity
Gerdeman, G. L., & Lovinger, D. M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705466 · Cited by 144
Hentges, S. T., Low, M. J., & Williams, J. T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2769-05.2005 · Cited by 143
Watanabe, M., Nakamura, M., Sato, K., Kano, M., Simon, M. I., & Inoue, Y. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00213.x · Cited by 143
Self-citationSzabó, B., Urbanski, M. J., Bisogno, T., Marzo, V. D., Mendiguren, A., Baer, W. U., & Freiman, I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.119362 · Cited by 142
Distribution of cells containing mRNA encoding cholecystokinin in the rat central nervous system
Schiffmann, S. N., & Vanderhaeghen, J. (1991) · The Journal of Comparative Neurology · doi:10.1002/cne.903040206 · Cited by 141
Hirasawa, M., Schwab, Y., Natah, S. S., Hillard, C. J., Mackie, K., Sharkey, K. A., & Pittman, Q. J. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.066159 · Cited by 140
Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein
Chakrabarti, A., Onaivi, E. S., & Chaudhuri, G. (1995) · DNA sequence · doi:10.3109/10425179509020870 · Cited by 140
A Role for Caveolae/Lipid Rafts in the Uptake and Recycling of the Endogenous Cannabinoid Anandamide
McFarland, M. J., Porter, A. C., Rakhshan, F., Rawat, D. S., Gibbs, R. A., & Barker, E. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407250200 · Cited by 139
Nuclear Calcium Signaling Evoked by Cholinergic Stimulation in Hippocampal CA1 Pyramidal Neurons
Power, J., & Sah, P. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03454.2002 · Cited by 138
Endocannabinoids in cognition and dependence
Lichtman, A. H., Varvel, S. A., & Martin, B. R. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0351 · Cited by 138
Godwin, D. W., Horn, S. C. V., Erişir, A., Sesma, M. A., Romano, C., & Sherman, S. M. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-24-08181.1996 · Cited by 137
Roberts, E. B., Meredith, M. A., & Ramoa, A. S. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.3.1021 · Cited by 137
Disruption of CB1 receptor signaling impairs extinction of spatial memory in mice
Varvel, S. A., Anum, E. A., & Lichtman, A. H. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2121-2 · Cited by 136
Altered Presynaptic Vesicle Release and Cycling during mGluR-Dependent LTD
Zakharenko, S. S., Zablow, L., & Siegelbaum, S. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00898-x · Cited by 136
Role of the endocannabinoid system in depression and suicide
Vinod, K. Y., & Hungund, B. L. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.08.006 · Cited by 135
Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain
Mori, F., Fukaya, M., Abe, H., Wakabayashi, K., & Watanabe, M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01046-6 · Cited by 135
Self-citationPresence and functional significance of presynaptic ryanodine receptors
Bouchard, R. A., Pattarini, R., & Geiger, J. D. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00053-4 · Cited by 134
Distribution of type 1 cannabinoid receptor (CB1)‐immunoreactive axons in the mouse hypothalamus
Wittmann, G., Deli, L., Kalló, I., Hrabovszky, E., Watanabe, M., Liposits, Z., & Fekete, C. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21383 · Cited by 134
Self-citationCannabinoids Inhibit the Formation of New Synapses between Hippocampal Neurons in Culture
Kim, D., & Thayer, S. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-10-j0004.2001 · Cited by 134
Marco, E. M., rez-Alvarez, L. P., Borcel, É., Rubio, M., Guaza, C., Ambrosio, E., File, S. E., & Viveros, M. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200402000-00003 · Cited by 133
Cannabinoid receptor homo- and heterodimerization
Mackie, K. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.011 · Cited by 132
Jordan, J. D., He, J. C., Eungdamrong, N. J., Gomes, I., Ali, W., Nguyen, T., Bivona, T. G., Philips, M. R., Devi, L. A., & Iyengar, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411521200 · Cited by 132
Walter, L. M., Dinh, T. P., & Stella, N. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2419-04.2004 · Cited by 132
Brain phospholipase C isozymes: differential mRNA localizations by in situ hybridization.
Ross, C. A., MacCumber, M. W., Glatt, C. E., & Snyder, S. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2923 · Cited by 131
Zhu, P., & Lovinger, D. M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1148-05.2005 · Cited by 131
Barnett‐Norris, J., Lynch, D. L., & Reggio, P. H. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.040 · Cited by 130
Weber, A., Ni, J., Ling, K.-H. J., Acheampong, A., Tang‐Liu, D. D., Burk, R. M., Cravatt, B. F., & Woodward, D. F. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300475-jlr200 · Cited by 130
Narushima, M., Uchigashima, M., Fukaya, M., Matsui, M., Manabe, T., Hashimoto, K., Watanabe, M., & Kano, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4644-06.2007 · Cited by 129
Self-citationSugiura, T., Kodaka, T., Kondo, S., et al. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021838 · Cited by 129
Mailleux, P., Parmentier, M., & Vanderhaeghen, J. J. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90265-9 · Cited by 128
Regulation of Gonadotropin-Releasing Hormone Secretion by Cannabinoids
Gammon, C. M., Freeman, G. M., Xie, W., Petersen, S. L., & Wetsel, W. C. (2005) · Endocrinology · doi:10.1210/en.2004-1672 · Cited by 128
Cadogan, A., Alexander, S. P. H., Boyd, E. A., & Kendall, D. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031131.x · Cited by 127
Kishimoto, Y., & Kano, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1236-06.2006 · Cited by 127
Self-citationCannabinoids Decrease the K+M-Current in Hippocampal CA1 Neurons
Schweitzer, P. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00051.2000 · Cited by 126
Choi, S., & Lovinger, D. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08613.1997 · Cited by 125
Di, S., Boudaba, C., Popescu, I., Weng, F., Harris, C., Marcheselli, V. L., Bazan, N. G., & Tasker, J. G. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.097477 · Cited by 124
Tanaka, J., Nakagawa, S., Kushiya, E., Yamasaki, M., Fukaya, M., Iwanaga, T., Simon, M. I., Sakimura, K., Kano, M., & Watanabe, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00959.x · Cited by 124
Self-citationSystemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex
Oropeza, V. C., Page, M. E., & Bockstaele, E. J. V. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.036 · Cited by 123
A role for endocannabinoids in indomethacin-induced spinal antinociception
Gühring, H., Hamza, M., Sergejeva, M., Ateş, M., Kotalla, C., Ledent, C. A., & Brune, K. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02485-8 · Cited by 123
Serotonin Evokes Endocannabinoid Release and Retrogradely Suppresses Excitatory Synapses
Best, A. R., & Regehr, W. G. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0678-08.2008 · Cited by 123
Salio, C., Fischer, J., Franzoni, M. F., & Conrath, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00584-x · Cited by 123
Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength
Mackie, K. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803273 · Cited by 123
Electrical Coupling among Irregular-Spiking GABAergic Interneurons Expressing Cannabinoid Receptors
Galarreta, M., Erdélyi, F., Szabó, G., & Hestrin, S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3027-04.2004 · Cited by 122
Rancz, E. A., & Häusser, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5284-05.2006 · Cited by 122
Kushmerick, C., Price, G. D., Taschenberger, H., Puente, N., Renden, R., Wadiche, J. I., Duvoisin, R. M., Grandes, P., & von Gersdorff, H. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0768-04.2004 · Cited by 122
Amaya, F., Shimosato, G., Kawasaki, Y., Hashimoto, S., Tanaka, Y., Ji, R., & Tanaka, M. (2006) · Pain · doi:10.1016/j.pain.2006.04.001 · Cited by 121
Cell type–specific gating of perisomatic inhibition by cholecystokinin
Földy, C., Lee, S. Y., Szabadics, J., Neu, A. D., & Soltész, I. (2007) · Nature Neuroscience · doi:10.1038/nn1952 · Cited by 121
Muntoni, A. L., Pillolla, G., Melis, M., Perra, S., Gessa, G. L., & Pistis, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04759.x · Cited by 121
An R-Type Ca2+Current in Neurohypophysial Terminals Preferentially Regulates Oxytocin Secretion
Wang, G., Dayanithi, G., Newcomb, R., & Lémos, J. R. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09235.1999 · Cited by 121
Simkus, C. R. L., & Stricker, C. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.022103 · Cited by 121
Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve
Derbenev, A. V., Stuart, T. C., & Smith, B. N. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.067470 · Cited by 120
Nyilas, R., Dudok, B., Urbán, G. M., Mackie, K., Watanabe, M., Cravatt, B. F., Freund, T. F., & Katona, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5102-07.2008 · Cited by 119
Endocannabinoids and neurodegenerative diseases
Micale, V., Mazzola, C., & Drago, F. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.008 · Cited by 119
Galante, M., & Diana, M. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0403-04.2004 · Cited by 118
Fortin, D. A., & Levine, E. S. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj133 · Cited by 118
Dendritic release of glutamate suppresses synaptic inhibition of pyramidal neurons in rat neocortex
Zilberter, Y. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00489.x · Cited by 118
Barrero, F. J., Ampuero, I., Morales, B., Vives, F., Luna, J. D. D., Hoenicka, J., & de Yébenes, J. G. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500301 · Cited by 117
Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin
Heifets, B. D., Chevaleyre, V., & Castillo, P. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711880105 · Cited by 116
Calcium Dependence of Retrograde Inhibition by Endocannabinoids at Synapses onto Purkinje Cells
Brenowitz, S. D., & Regehr, W. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06373.2003 · Cited by 116
Multiple Mechanisms of Endocannabinoid Response Initiation in Hippocampus
Edwards, D. A., Kim, J., & Alger, B. E. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00813.2005 · Cited by 116
Nakane, S., Oka, S., Arai, S., Waku, K., Ishima, Y., Tokumura, A., & Sugiura, T. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00038-3 · Cited by 116
Cristino, L., Starowicz, K., De Petrocellis, L., Morishita, J., Ueda, N., Guglielmotti, V., & Di Marzo, V. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.047 · Cited by 115
Dani, M., Guindon, J., Lambert, C., & Beaulieu, P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.07.012 · Cited by 115
Paquet, M., & Smith, Y. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07659.2003 · Cited by 115
Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation
Cahill, K., & USSHER, M. H. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005353.pub2 · Cited by 114
Trettel, J., & Levine, E. S. (2003) · Journal of Neurophysiology · doi:10.1152/jn.01037.2002 · Cited by 113
Learning Impairment Produced in Rats by the Cannabinoid Agonist HU 210 in a Water-Maze Task
Ferrari, F., Ottani, A., Vivoli, R., & Giuliani, D. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00106-9 · Cited by 113
Endocannabinoids and related fatty acid derivatives in pain modulation
Walker, J. M., Krey, J. F., Chu, C. J., & Huang, S. M. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00152-4 · Cited by 113
Timing dependence of the induction of cerebellar LTD
Safo, P. K., & Regehr, W. G. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.029 · Cited by 113
Toledo‐Rodriguez, M., Goodman, P. H., Illic, M., Wu, C., & Markram, H. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.089250 · Cited by 113
Nirodi, C. S., Crews, B. C., Kozak, K. R., Morrow, J. D., & Marnett, L. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303950101 · Cited by 113
Wang, Y., Rowan, M. J., & Anwyl, R. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.2.812 · Cited by 113
Miyata, M., Kim, H., Hashimoto, K., Lee, T., Cho, S. Y., Jiang, H., Wu, Y., Jun, K., Wu, D., Kano, M., et al. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01570.x · Cited by 112
Self-citationSavinainen, J. R., Saario, S. M., Niemi, R., Järvinen, T., & Laitinen, J. T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705577 · Cited by 112
Usachev, Y. M., & Thayer, S. A. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-19-07404.1997 · Cited by 112
Pharmacology of Cannabinoid CB 1 and CB 2 Receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · Cited by 112
Egertová, M., Simon, G. M., Cravatt, B. F., & Elphick, M. R. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21568 · Cited by 111
Fattore, L., Spano, M. S., Deiana, S., Melis, V., Cossu, G., Fadda, P., & Fratta, W. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.05.003 · Cited by 110
Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse
Wallmichrath, I., & Szabó, B. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00109-4 · Cited by 110
Glitsch, M. D., Llano, I., & Marty, A. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021786 · Cited by 110
A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders
Witkin, J. M., Tzavara, E. T., Davis, R. J., Li, X., & Nomikos, G. G. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.006 · Cited by 110
Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity
Strangman, N. M., Patrick, S. L., Hohmann, A. G., Tsou, K., & Walker, J. M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)01031-2 · Cited by 109
Morishita, W., Kirov, S. A., & Alger, B. E. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04870.1998 · Cited by 109
King, A. R., Duranti, A., Tontini, A., Rivara, S., Rosengarth, A., Clapper, J. R., Astarita, G., Geaga, J. A., Luecke, H., Mor, M., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.10.017 · Cited by 108
Russo, P., Strazzullo, P., Cappuccio, F. P., Trégouët, D., Lauria, F., Loguercio, M., Barba, G., Versiero, M., & Siani, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2523 · Cited by 108
Oliet, S. H. R., Baimoukhametova, D. V., Piet, R., & Bains, J. S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2676-06.2007 · Cited by 107
Nunzi, M. G., Shigemoto, R., & Mugnaini, E. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10344 · Cited by 105
The contribution of cyclooxygenase‐2 to endocannabinoid metabolism and action
Fowler, C. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707379 · Cited by 104
Sandler, V. M., & Barbara, J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04325.1999 · Cited by 104
Anandamide hydrolysis: a new target for anti-anxiety drugs?
Gaetani, S., Cuomo, V., & Piomelli, D. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.09.005 · Cited by 104
Galante, M., & Marty, A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11229.2003 · Cited by 103
Vemuri, K. V., Janero, D. R., & Makriyannis, A. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.012 · Cited by 103
Endocannabinoid-Dependent Neocortical Layer-5 LTD in the Absence of Postsynaptic Spiking
Sjöström, P. J., Turrigiano, G. G., & Nelson, S. B. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00376.2004 · Cited by 102
Ronesi, J. A., & Lovinger, D. M. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.068460 · Cited by 101
Araya, R., Noguchi, T., Yuhki, M., Kitamura, N., Higuchi, M., Saido, T. C., Seki, K., Itohara, S., Kawano, M., Tanemura, K., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.010 · Cited by 100
Ujike, H., & Morita, Y. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fmj04003x4 · Cited by 98
Harkany, T., Holmgren, C. D., Härtig, W., Qureshi, T., Chaudhry, F. A., Storm‐Mathisen, J., Dobszay, M. B., Berghuis, P., Schulte, G., Sousa, K. M., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4884-03.2004 · Cited by 98
Narushima, M., Uchigashima, M., Hashimoto, K., Watanabe, M., & Kano, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05119.x · Cited by 97
Self-citationLack of selectivity of URB602 for 2‐oleoylglycerol compared to anandamide hydrolysis in vitro
Vandevoorde, S., Jonsson, K., Labar, G., Persson, E., Lambert, D. M., & Fowler, C. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706971 · Cited by 97
Cortical sources of CRF, NKB, and CCK and their effects on pyramidal cells in the neocortex
Gallopin, T., Geoffroy, H., Rossier, J., & Lambolez, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj081 · Cited by 97
Oka, S., Tsuchie, A., Tokumura, A., Muramatsu, M., Suhara, Y., Takayama, H., Waku, K., & Sugiura, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01804.x · Cited by 96
Martin, L., Blackstone, C. D., Levey, A. I., Huganir, R. L., & Price, D. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-05-02249.1993 · Cited by 95
Inhibitory effects of SR141716A on G-protein activation in rat brain
Sim‐Selley, L. J., Brunk, L. K., & Selley, D. E. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00784-1 · Cited by 95
Chavarría‐Siles, I., Rojas, J. C., Hare, E., Walss‐Bass, C., Quezada, P., Dassori, A. M., Contreras, S. A., Medina, R., Ramírez, M., Salazar, R., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30592 · Cited by 95
Croxford, J. L., Pryce, G., Jackson, S. J., Ledent, C. A., Giovannoni, G., Pertwee, R. G., Yamamura, T., & Baker, D. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.10.024 · Cited by 94
Mechanisms for Synapse Specificity during Striatal Long-Term Depression
Singla, S., Kreitzer, A. C., & Malenka, R. C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0018-07.2007 · Cited by 94
Mu, J., Zhuang, S.-Y., Kirby, M. T., Hampson, R. E., & Deadwyler, S. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35181-x · Cited by 93
Two distinct subgroups of cholecystokinin-immunoreactive cortical interneurons
Kubota, Y., & Kawaguchi, Y. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01446-1 · Cited by 93
Retrograde signaling at GABAA-receptor synapses in the mammalian CNS
Alger, B. E., & Pitler, T. A. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93923-l · Cited by 93
Chan, P. K. Y., Chan, C. S., & Yung, W. (1998) · Neuroreport · doi:10.1097/00001756-199803090-00020 · Cited by 93
Slanina, K. A., & Schweitzer, P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.019 · Cited by 92
Hashimotodani, Y., Ohno‐Shosaku, T., Maejima, T., Fukami, K., & Kano, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.002 · Cited by 92
Self-citationPossible involvement of the endocannabinoid system in the actions of three clinically used drugs
Fowler, C. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.12.001 · Cited by 91
McFarland, M. J., & Barker, E. L. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.07.008 · Cited by 91
Sang, N., Zhang, J., & Chen, C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04668.x · Cited by 90
Seymour-Laurent, K. J., & Barish, M. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-04-02592.1995 · Cited by 90
Sang, N., Zhang, J., & Chen, C. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.105569 · Cited by 89
Extensive co-existence of neuropeptides in the rat visual cortex
Papadopoulos, G. C., Parnavelas, J. G., & Cavanagh, M. E. (1987) · Brain Research · doi:10.1016/0006-8993(87)90243-5 · Cited by 89
Depression and anxiety with rimonabant
Mitchell, P. B., & Morris, M. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61705-x · Cited by 89
Peng, Y.-Y. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-21-06703.1996 · Cited by 88
Khasabova, I. A., Harding-Rose, C., Simone, D. A., & Seybold, V. S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4298-03.2004 · Cited by 88
Cannabinoid modulation of rat pup ultrasonic vocalizations
McGregor, I. S., Dastur, F. N., McLellan, R. A., & Brown, R. E. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00511-0 · Cited by 88
Exon–intron organization and chromosomal localization of the mouse monoglyceride lipase gene
Karlsson, M., Reue, K., Xia, Y.-R., Lusis, A. J., Langin, D., Tornqvist, H. E., & Holm, C. (2001) · Gene · doi:10.1016/s0378-1119(01)00559-5 · Cited by 87
Benedeczky, I., Molnár, E., & Somogyi, P. (1994) · Experimental Brain Research · doi:10.1007/bf00228742 · Cited by 87
Makara, J. K., Katona, I., Nyíri, G., Németh, B., Ledent, C. A., Watanabe, M., de Vente, J., Freund, T. F., & Hájos, N. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2104-07.2007 · Cited by 87
Self-citationHashimotodani, Y., Ohno‐Shosaku, T., & Kano, M. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.03.012 · Cited by 87
Self-citationSalio, C., Doly, S., Fischer, J., Franzoni, M. F., & Conrath, M. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00549-9 · Cited by 86
Rouse, S. T., Edmunds, S. M., Yi, H. L., Gilmor, M. L., & Levey, A. I. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01011-9 · Cited by 85
Associative Long-Term Depression in the Hippocampus Is Dependent on Postsynaptic N-Type Ca2+Channels
Normann, C., Peckys, D. B., Schulze, C. H., Walden, J., Jónás, P., & Bischofberger, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08290.2000 · Cited by 85
Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line
Rimmerman, N., Hughes, V., Bradshaw, H. B., Pazos, M., Mackie, K., Prieto, A. L., & Walker, J. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707561 · Cited by 84
Beinfeld, M. C., & Connolly, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01591-9 · Cited by 84
Daniel, H., & Crépel, F. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00793.x · Cited by 84
Trettel, J., Fortin, D. A., & Levine, E. S. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.058198 · Cited by 84
Absolute quantification of AMPA receptor subunit mRNAs in single hippocampal neurons
Tsuzuki, K., Lambolez, B., Rossier, J., & Ozawa, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00388.x · Cited by 83
Mátyás, F., Freund, T. F., & Gulyás, A. I. (2004) · Hippocampus · doi:10.1002/hipo.10191 · Cited by 81
Hoffman, A. F., Riegel, A. C., & Lupica, C. R. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02773.x · Cited by 81
Sutherland, R. J., & Rudy, J. W. (1988) · Psychobiology · doi:10.3758/bf03333120 · Cited by 80
Drew, G. M., Mitchell, V. A., & Vaughan, C. W. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4876-07.2008 · Cited by 80
Efficacy in CB1 receptor‐mediated signal transduction
Howlett, A. C. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705881 · Cited by 80
Local Interneurons Regulate Synaptic Strength by Retrograde Release of Endocannabinoids
Beierlein, M., & Regehr, W. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0958-06.2006 · Cited by 79
Yamasaki, M., Hashimoto, K., & Kano, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2258-05.2006 · Cited by 79
Self-citationAteş, M., Hamza, M., Seidel, K., Kotalla, C., Ledent, C. A., & Gühring, H. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02470.x · Cited by 78
Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats
Marı́n, S., Marco, E. M., Biscaia, M., Fernández, B., Rubio, M., Guaza, C., Schmidhammer, H., & Viveros, M. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01041-9 · Cited by 78
Kishimoto, Y., Fujimichi, R., Araishi, K., Kawahara, S., Kano, M., Aiba, A., & Kirino, Y. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02407.x · Cited by 78
Self-citationBeierlein, M., Fioravante, D., & Regehr, W. G. (2007) · Neuron · doi:10.1016/j.neuron.2007.06.002 · Cited by 78
Zhu, P., & Lovinger, D. M. (2007) · Journal of Neurophysiology · doi:10.1152/jn.01228.2006 · Cited by 77
Binzen, U., Greffrath, W., Hennessy, S., Bausen, M., Saaler‐Reinhardt, S., & Treede, R. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.020 · Cited by 77
Fortin, D. A., Trettel, J., & Levine, E. S. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00351.2004 · Cited by 77
Turu, G., Simon, A., Gyombolai, P., Szidonya, L. K., Bagdy, G., Lenkei, Z., & Hunyady, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c600318200 · Cited by 77
Cited by
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
An Introduction to the Endogenous Cannabinoid System
Lu, H.-C., & Mackie, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.028 · Cited by 1,234
Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,120
Self-citationHippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3278 · Cited by 867
Metadata
- Authors
- Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2009-01
- Volume
- 89
- Issue
- 1
- Pages
- 309-380
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W2116562654
- Cited by
- 1,529
- References
- 692
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.